Records containing: Stage III Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-07-10Phase II Study of Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-05-31The Treatment of Multiple Myeloma Utilizing VBMCP Chemotherapy Alternating With High-Dose Cyclophosphamide and Alpha2b-Interferon Versus VBMCP: A Phase III Study for Previously Untreated Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-05-16A Phase I Pharmacokinetic Study of PS341 in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group
-
CLINICAL_TRIALS study record update · 2013-03-27CTLA-4 Blockade With MDX-010 to Induce Graft-Versus-Malignancy Effects Following Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-03-19A Phase I Study of the Raf Kinase/VEGFR Inhibitor BAY 43-9006 in Combination With the Proteasome Inhibitor PS-341 in Patients With Advanced Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-03-06A Phase II Trial of Sunitinib (SU11248) in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-02-15A Phase I/Pilot Study of Intravenous PLERIXAFOR Following Cyclophosphamide Mobilization in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase II Study of Flavopiridol in Patients With Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase I and Pharmacologic Study of 2-Methoxyestradiol in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-01-11A Phase I Trial of Combination Bryostatin 1 (NSC 339555) and Vincristine in B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-07Pharmacokinetic and Phase I Study of Sorafenib (BAY 43-9006, NSC 724772, IND 69896) for Solid Tumors and Hematologic Malignancies in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2012-09-28Phase II Study of PS-341 for Patients With High-Risk, Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2012-07-30Phase II Trial of Intravenously Administered AMD3100 (Plerixafor) for Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Following a Lenalidomide Based Initial Therapy
-
CLINICAL_TRIALS study record update · 2012-03-07INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation